View in EDS PDF Full Text

Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies.

Saved in:
Bibliographic Details
Title: Lixisenatide: A New Member of the Glucagon-Like Peptide 1 Receptor Agonist Class of Incretin Therapies.
Authors: Shaefer Jr., Charles F.1 cshaefer@uh.org
Source: Clinical Diabetes. Spring2016, Vol. 34 Issue 2, p81-85. 5p.
Database: Academic Search Ultimate
Description
ISSN:08918929
DOI:10.2337/diaclin.34.2.81